High-dose glucagon infusion (12.5 ng/kg/min or 25 ng/kg/min, giving plasma glucagon levels of around 85 pmol/L) reduces circulating amino acids in patients with obesity and increases urinary nitrogen excretion (Vega et al. 2021). This evidence concerns the gene GCG and Obesity.